Congressional opioid efforts targeting Medicare, limits on new prescriptions
Published by McKnight’s Long-Term Care News
A bipartisan group of senators introduced legislation Tuesday that would set a three-day initial prescribing limit on opioids for acute pain and increase recovery services and availability for addicts.
The legislation would change policies and make more funding available through the $6 billion earmarked for opioids and mental health treatment in a two-year budget deal struck last month.
The Senior Care Pharmacy Coalition urged lawmakers to stick with the precedent established in 2016 and exempt long-term care facilities from the proposed three-day limit. The current version only includes an exception for hospice care.
“Patients in long-term care settings are at very low risk for opioid abuse, and those prescribed opioids suffer intense and severe pain which mean that some dispensing limits inadvertently threaten effective pain management,” said Alan G. Rosenbloom, SCPC president and CEO.
One in three participants in Medicare’s prescription drug program received a prescription for opioids in 2016, according to the Office of Inspector General. Across the country, overdose deaths increased nearly 28% from 2015 to 2016, according to the latest data from the Centers for Disease Control and Prevention.
The House Energy and Commerce Committee held its first of three hearings Wednesday to discuss legislation, while the Ways and Means Committee has already made it clear Medicare’s handling of opioids will be in its sights.
The committee has asked insurers, benefit managers, providers and prescribers to submit information by March 15 that addresses how Medicare can help stem the epidemic. Members specifically want information on overprescribing, data tracking, treatment, communication and education, The Hill reported.
Recent Posts
-
Rep. Beth Van Duyne: Congress can save seniors’ access to medications before it’s too late
Seniors in nursing homes across the country depend on round-the-clock care and medications, perhaps more than any other American patient population. In turn, the nursing homes and assisted living facilities that care for them depend on a small number of specialized long-term care (LTC) pharmacies to ensure their patients have access to the prescription meds they need.
-
Bill Aims to Offset Reimbursement Losses for Long-Term Care Pharmacies Catering to Nursing Homes
Starting in January, falling prices for costly drugs may strain long-term care pharmacies, but proposed legislation backed by advocacy groups aims to subsidize some of this loss. And nursing home advocacy groups are among those urging Congress to pass the Preserving Patient Access to Long-Term Care Pharmacies Act.
-
Drug pricing policy could jeopardize long-term care pharmacies, leaders contend
Senior living and care leaders have joined a coalition calling attention to a policy fix they say would address unintended consequences of Medicare Part D price negotiations that could shutter long-term care pharmacies.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.